Equities research analysts expect Joint Corp (NASDAQ:JYNT) to announce $8.78 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Joint’s earnings, with the highest sales estimate coming in at $8.80 million and the lowest estimate coming in at $8.76 million. Joint reported sales of $7.10 million during the same quarter last year, which indicates a positive year-over-year growth rate of 23.7%. The company is scheduled to announce its next earnings results on Thursday, May 9th.
According to Zacks, analysts expect that Joint will report full year sales of $39.21 million for the current financial year, with estimates ranging from $39.00 million to $39.42 million. For the next fiscal year, analysts anticipate that the business will report sales of $47.10 million. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for Joint.
Get Joint alerts:Joint (NASDAQ:JYNT) last posted its earnings results on Thursday, March 7th. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.01. Joint had a negative net margin of 2.68% and a negative return on equity of 21.00%. The company had revenue of $9.07 million for the quarter, compared to analyst estimates of $8.65 million.
Several equities research analysts recently weighed in on the stock. Maxim Group reaffirmed a “buy” rating and set a $18.00 target price (up from $11.00) on shares of Joint in a research note on Friday. DA Davidson upped their target price on shares of Joint to $15.00 and gave the stock a “buy” rating in a research note on Friday. Lake Street Capital upped their target price on shares of Joint to $20.00 and gave the stock a “buy” rating in a research note on Friday. Finally, ValuEngine raised shares of Joint from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, February 20th. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $14.95.
Shares of JYNT stock traded up $1.43 during trading hours on Monday, hitting $13.45. The company had a trading volume of 388,501 shares, compared to its average volume of 70,322. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.36 and a current ratio of 1.36. Joint has a fifty-two week low of $5.01 and a fifty-two week high of $13.49. The firm has a market cap of $150.11 million, a P/E ratio of -53.80, a P/E/G ratio of 3.77 and a beta of 0.62.
In related news, Director James H. Amos, Jr. bought 5,000 shares of the stock in a transaction dated Thursday, December 20th. The stock was acquired at an average price of $6.79 per share, for a total transaction of $33,950.00. Following the acquisition, the director now owns 77,797 shares in the company, valued at approximately $528,241.63. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 3.20% of the company’s stock.
Institutional investors and hedge funds have recently made changes to their positions in the company. Northern Trust Corp increased its holdings in Joint by 16.1% during the 4th quarter. Northern Trust Corp now owns 16,614 shares of the company’s stock valued at $138,000 after acquiring an additional 2,300 shares in the last quarter. Alambic Investment Management L.P. purchased a new stake in shares of Joint during the fourth quarter worth about $152,000. Globeflex Capital L P purchased a new stake in shares of Joint during the fourth quarter worth about $210,000. Advisory Services Network LLC grew its holdings in shares of Joint by 42.6% during the third quarter. Advisory Services Network LLC now owns 27,780 shares of the company’s stock worth $238,000 after buying an additional 8,299 shares in the last quarter. Finally, Granite Investment Partners LLC grew its holdings in shares of Joint by 40.5% during the third quarter. Granite Investment Partners LLC now owns 79,492 shares of the company’s stock worth $680,000 after buying an additional 22,900 shares in the last quarter. Institutional investors and hedge funds own 47.62% of the company’s stock.
Joint Company Profile
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics in the United States. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of December 31, 2018, the company operated 442, including 394 franchised clinics, and 48 corporate owned or managed clinics.
Featured Article: How dollar cost averaging works
Get a free copy of the Zacks research report on Joint (JYNT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
No comments:
Post a Comment